Kevin M. Picardat

Array ( [id] => 4543504 [patent_doc_number] => 07959933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Activatable recombinant neurotoxins' [patent_app_type] => utility [patent_app_number] => 12/182801 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 22 [patent_no_of_words] => 15884 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/959/07959933.pdf [firstpage_image] =>[orig_patent_app_number] => 12182801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994793 [patent_doc_number] => 08518677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Microbial bioreaction process' [patent_app_type] => utility [patent_app_number] => 12/670709 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 20368 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12670709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270169 [patent_doc_number] => 08211671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Activatable recombinant neurotoxins' [patent_app_type] => utility [patent_app_number] => 12/177415 [patent_app_country] => US [patent_app_date] => 2008-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 22 [patent_no_of_words] => 15906 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12177415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852041 [patent_doc_number] => 20080317783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'CLOSTRIDIAL TOXIN DERIVATIVES AND METHODS FOR TREATING PAIN' [patent_app_type] => utility [patent_app_number] => 12/175621 [patent_app_country] => US [patent_app_date] => 2008-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13101 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317783.pdf [firstpage_image] =>[orig_patent_app_number] => 12175621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122108 [patent_doc_number] => 07704512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Clostridial toxin derivatives and methods for treating pain' [patent_app_type] => utility [patent_app_number] => 12/175288 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13119 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704512.pdf [firstpage_image] =>[orig_patent_app_number] => 12175288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 111883 [patent_doc_number] => 07718607 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Method of producing S-nitrosoprotein preparation' [patent_app_type] => utility [patent_app_number] => 12/218059 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3820 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718607.pdf [firstpage_image] =>[orig_patent_app_number] => 12218059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6247328 [patent_doc_number] => 20100136636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'PROCESS FOR SELECTIVE PRODUCTION OF THEAFLAVIN' [patent_app_type] => utility [patent_app_number] => 12/452557 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7922 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136636.pdf [firstpage_image] =>[orig_patent_app_number] => 12452557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932415 [patent_doc_number] => 08492113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Measurement of protein using inclusion body dry weight' [patent_app_type] => utility [patent_app_number] => 12/667665 [patent_app_country] => US [patent_app_date] => 2008-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5156 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12667665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7801229 [patent_doc_number] => 08129501 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Dispersion improver for gluten, and dispersion solution of gluten' [patent_app_type] => utility [patent_app_number] => 12/452528 [patent_app_country] => US [patent_app_date] => 2008-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 12216 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129501.pdf [firstpage_image] =>[orig_patent_app_number] => 12452528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324211 [patent_doc_number] => 20090062201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES' [patent_app_type] => utility [patent_app_number] => 12/167491 [patent_app_country] => US [patent_app_date] => 2008-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10149 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062201.pdf [firstpage_image] =>[orig_patent_app_number] => 12167491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852124 [patent_doc_number] => 20080317866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'COLLAGEN-BASED MICROSPHERES AND METHODS OF PREPARATION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/166670 [patent_app_country] => US [patent_app_date] => 2008-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7360 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317866.pdf [firstpage_image] =>[orig_patent_app_number] => 12166670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6623153 [patent_doc_number] => 20100311118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'PLASMID-ENCODED NEUROTOXIN GENES IN CLOSTRIDIUM BOTULINUM SEROTYPE A SUBTYPES' [patent_app_type] => utility [patent_app_number] => 12/664800 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6117 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311118.pdf [firstpage_image] =>[orig_patent_app_number] => 12664800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9608230 [patent_doc_number] => 08785397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Cosmetic use of apolipoprotein D type proteins' [patent_app_type] => utility [patent_app_number] => 12/602246 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8424 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12602246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8103525 [patent_doc_number] => 08153410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules' [patent_app_type] => utility [patent_app_number] => 12/142435 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 68 [patent_no_of_words] => 59744 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 233 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153410.pdf [firstpage_image] =>[orig_patent_app_number] => 12142435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7500437 [patent_doc_number] => 20110262950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'REDOX MEDIATORS' [patent_app_type] => utility [patent_app_number] => 12/663821 [patent_app_country] => US [patent_app_date] => 2008-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 16121 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262950.pdf [firstpage_image] =>[orig_patent_app_number] => 12663821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 73294 [patent_doc_number] => 07749515 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Targeted delivery of botulinum toxin to the sphenopalatine ganglion' [patent_app_type] => utility [patent_app_number] => 12/136503 [patent_app_country] => US [patent_app_date] => 2008-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8069 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/749/07749515.pdf [firstpage_image] =>[orig_patent_app_number] => 12136503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664126 [patent_doc_number] => 20080255033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Metallopeptide gamma-Melanocyte Stimulating Hormone Compounds' [patent_app_type] => utility [patent_app_number] => 12/136233 [patent_app_country] => US [patent_app_date] => 2008-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16231 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255033.pdf [firstpage_image] =>[orig_patent_app_number] => 12136233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960077 [patent_doc_number] => 20080274502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Bacillus Thuringiensis CryET33 and CryET34 Compositions and Uses Therefor' [patent_app_type] => utility [patent_app_number] => 12/135475 [patent_app_country] => US [patent_app_date] => 2008-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26530 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274502.pdf [firstpage_image] =>[orig_patent_app_number] => 12135475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760188 [patent_doc_number] => 20080312414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'APPARATUS FOR MEASURING HIGH DENSITY LIPOPROTEINS AND METHOD OF SEPARATING HIGH DENSITY LIPOPROTEINS' [patent_app_type] => utility [patent_app_number] => 12/131438 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5334 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312414.pdf [firstpage_image] =>[orig_patent_app_number] => 12131438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264940 [patent_doc_number] => 20090117625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Polypeptides and Biosynthetic Pathways for the Production of Monatin and Its Precursors' [patent_app_type] => utility [patent_app_number] => 12/124014 [patent_app_country] => US [patent_app_date] => 2008-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 31312 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117625.pdf [firstpage_image] =>[orig_patent_app_number] => 12124014 [rel_patent_id] =>[rel_patent_doc_number] =>)